REGENERON PHARMACEUTICALS, INC.: operating_income
| Value | {"amount": 2079591000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2017-01-01 – 2017-12-31 |
| Status | superseded |
| Entity | REGENERON PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:39:09.179697+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/db997fae-38ec-4abf-8810-759fc5cadc25
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001532176-18-000013Retrieved: 2026-08-19T08:39:09.179697+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000872589/operating-income/2017-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/db997fae-38ec-4abf-8810-759fc5cadc25
History
- no predecessors — first report